Tulozin in combined treatment of patients with acute urinary retention


Citar

Texto integral

Resumo

There is much evidence that tulozin promotes recovery of spontaneous urination, Qmax and is effective in combined treatment of patients with acute retention of urine caused by prostatic adenoma. Tulozin produces positive changes in the lower urinary tract symptoms. Rare occurrence of side effects enables long-term treatment and achievement of good therapeutic response. Tulozin is recommended for patients of younger age, with minimal comorbid pathology, hypotonic with orthostatic reactions, history of side effects in the treatment of other alpha-adrenoblockers, in comorbid hypertention, hypercholesterolemia, retrograde ejaculation, low potention, overactive bladder, prostatitis, after prostatic TUR, transvesical adenomectomy.

Bibliografia

  1. Finley R. K. Jr., Miller S. F., Jones L. M. Elimination of urinary retention following herniorraphy. Am. Surg. 1991; 57: 486-488.
  2. Kemp D., Tabaka N. Postoperative urinary retention: Part II-A retrospective study. J. Post. Anesth. Nurs. 1990; 5: 397-400.
  3. McNeill S. A. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obtruction. Eur. Urol. 2004; 45 (3): 325-332.
  4. Kim H. L., Kim J. C., Benson D. A. et al. Results of treatment with tamsulosin in men with acute urinary retention. Tech. Urol. 2001; 7 (4): 256-260.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2009